Society of Interventional Oncology: Research Grant Opportunities 

This Society of Interventional Oncology (SIO) Grant is designed to fund research initiatives that:

• Evaluate immune stimulation of interventional oncologic therapies,
• Combine approaches to improve clinical outcome, and
• Improve the understanding of underlying mechanisms as to how different therapies influence both adaptive and innate immunity, as well as underlying inflammation and tumorigenesis.

SIO and Guerbet, LLC Announce Grant Recipients: 

The Society of Interventional Oncology (SIO), a global organization working to advance interventional oncology worldwide, working in collaboration with Guerbet LLC, announce their 2018 transarterial Lipiodol® chemoembolization grant recipients.

The investigators and project proposals that have been awarded grants are:

F. Edward Boas
Memorial Sloan Kettering Cancer Center
Phase I Study of Transarterial Chemoembolization of Lung Metastases

Julius Chapiro
Yale University School of Medicine
Molecular Imaging of the Tumor Microenvironment and Immune Response in TACE

Terence Gade
Hospital of the University of Pennsylvania
Targeting the Metabolic Stress Response in Hepatocellular Carcinoma

Anil K. Pilla
University of Texas Health Science Center at Houston
Identify Proteomic Biomarkers for Outcome Prediction of Lipiodol® TACE Treatment